Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.
Generex Biotechnology Corporation recently presented an update on the status of a buccal insulin formulation enhancement project for Generex Oral-lyn™, the company’s proprietary buccal insulin spray ... Read more
The United States Food and Drug Administration (FDA) recently approved Synjardy, an oral therapy developed by Boehringer Ingelheim Pharmaceuticals Inc and Eli Lilly, as ... Read more
Thanks to advances in genomic testing, infants suffering from diabetes are beginning to be genetically tested for all 22 genetic causes of the disease. The ... Read more
The Hass Avocado Board (HAB) is joining the American Diabetes Association® for the national Stop Diabetes® movement with the goal of boosting awareness ... Read more
Echo Therapeutics, Inc., a medical device company committed to advancing non-invasive continuous glucose monitoring (CGM) and similar technologies, recently announced that, after several requests ... Read more
DexCom, Inc., a biotechnology company that develops continuous glucose monitoring (CGM) technology for those who suffer from diabetes, recently announced it has signed an agreement ... Read more
According to a recent study published in the Neurology journal, over the course of two years, study participants with type 2 diabetes experienced negative changes in their ability to regulate blood ... Read more
Oklahoma Medical Research Foundation researchers have identified a cell that sets off the process of scarring in fatty tissue. These findings represent new insights ... Read more
